We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bioinformatics Provides Clues into Interspecies Genetic Similarities

By LabMedica International staff writers
Posted on 30 May 2012
European scientists have confirmed the long-held belief that studying the genes humans and animals share provides vital insights into similar biologic processes. More...


The study’s findings, published May 17, 2012, in the open access journal PLoS Computational Biology, revealed how bioinformatics makes it possible to study the most basic tenets on which life science is constructed. Examining genes helps life science researchers better determine how the human body functions and how diseases progress. Scientists have long studied model species--mice, for example--to understand human biology better. This is at the basis of what is called the “ortholog conjecture,” the hypothesis that one can take what scientists learn from a few species and apply it to many.

In genetics, scientists address a questions such as, is it better to compare genes in mice and humans that directly descend from a common ancestor (these are called orthologs) --or to compare flawed copies of genes within a human being (the ‘paralogs’)? For the past 40 years, scientists have gone with the ortholog strategy, and this has worked very well. Studying genes in model species has provided invaluable insights in all areas of biology. However, until now, there has not been enough data to resolve this question with confidence. With developments in biotechnology generating vast quantities of data every day, there is finally enough to resolve the debate.

Using sophisticated computational techniques on data derived from tens of thousands of scientific articles, the researchers, from the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland; www.isb-sib.ch) and the European Molecular Biology Laboratory (EMBL)-European Bioinformatics Institute (Hinxton, Cambridgeshire, UK), analyzed 400,000 pairs of genes (orthologs and paralogs) from 13 different species. The team compared the two approaches and chose the best strategy.

“We have the data to prove that the study of orthologs is indeed useful, but we are only at the beginning,” said Prof. Marc Robinson-Rechavi of SIB and the University of Lausanne (Switzerland). “This is at the heart of all of comparative genomics, in which we try to extrapolate knowledge from a handful of organisms and apply it to all of life.”

“We found that current experimental annotations do support the standard model,” explained Christophe Dessimoz of EMBL-EBI. “Our work corroborates the assumption that studying the genes of other species--whether mice, yeast, or even bacteria--can elucidate aspects of human biology.”

The same question has recently been addressed by Matthew Hahn and colleagues from the University of Indiana (IN, USA), whose different conclusion triggered some debate. The new research demonstrates that these controversial findings were due to overlooked biases in the collective knowledge of gene function. Controlling for these, the new study unequivocally supports the ortholog conjecture and the fact that studying species we are only distantly related to--even worms, flies, yeasts, or bacteria--is pertinent and useful.

All of the data used in the study was freely available, including the genome sequences and research knowledge described in thousands of publications. EMBL-European Bioinformatics Institute’s ELIXIR will build on this innovation and provide the next generation of infrastructure for biologic information in Europe and worldwide. The purpose of ELIXIR is to construct and operate a sustainable infrastructure for biologic data in Europe to support life science research and its translation to medicine and the environment, the bioindustries, and society.

Related Links:

SIB Swiss Institute of Bioinformatics
European Molecular Biology Laboratory-European Bioinformatics Institute
ELIXIR



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.